Insider Transactions in Q2 2023 at Protagonist Therapeutics, Inc (PTGX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2023
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,165
-1.98%
|
$316,290
$26.07 P/Share
|
|
May 31
2023
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+4.65%
|
-
|
|
May 31
2023
|
Suneel Gupta Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-2.73%
|
$107,900
$26.07 P/Share
|
|
May 31
2023
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+7.31%
|
-
|
|
May 31
2023
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-11.79%
|
$107,900
$26.07 P/Share
|
|
May 31
2023
|
Asif Ali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+25.43%
|
-
|
|
Apr 18
2023
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-4.88%
|
$27,347
$23.21 P/Share
|
|
Apr 10
2023
|
Harold E Selick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,196
+22.37%
|
$0
$0.87 P/Share
|